Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey
暂无分享,去创建一个
S. Ng | G. Kaplan | A. Griffiths | D. Rubin | S. Travis | C. Bernstein | R. Gearry | D. Ong | Z. Abbas | S. Hamid | N. Pausawasdi | J. Yamamoto-Furusho | D. Armstrong | A. Sood | E. Benchimol | F. Carbonnel | K. Goh | Suk-Kyun Yang | J. Limsrivilai | G. Kochhar | E. Torres | F. Magro | Majid Abdulrahman Almadi | Yinglei Miao | J. Sollano | B. Shen | M. Diculescu | G. Watermeyer | S. Devani | R. Banerjee | Y. Chowers | I. Hilmi | T. Aye | Marta B Machado | S. Lopes | N. Joshi | R. R. Raja Ali | F. Steinwurz | Mahmoud Omar | J. Mak | M. M. Rahman | Ximena Rodríguez | M. Abdullah | S. Mohiuddin | M. N. Mohsin | T. M. Wai | Andrea Vieira | Nayara Carvalho Salgado | Hao Wu | E. Ogutu | Navarathne Metthananda | Shuchen Wei | Pises Pisepongsa | D. Viet
[1] M. Kappelman,et al. Reply , 2021, Gastroenterology.
[2] S. Ng,et al. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry , 2020, Gastroenterology.
[3] Evan T. Sholle,et al. Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications , 2020, Gastroenterology.
[4] H. El‐Serag,et al. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19 , 2020, Gastroenterology.
[5] S. Vavricka,et al. Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn’s and Colitis Organization , 2020, Gastroenterology.
[6] E. Pham,et al. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California , 2020, Gastroenterology.
[7] D. Rubin,et al. AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary , 2020, Gastroenterology.
[8] Haibo Xu,et al. Don't Overlook Digestive Symptoms in Patients With 2019 Novel Coronavirus Disease (COVID-19) , 2020, Clinical Gastroenterology and Hepatology.
[9] S. Ng,et al. Changing Global Epidemiology of Inflammatory Bowel Diseases-Sustaining Healthcare Delivery into the 21st Century. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] S. Ng,et al. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean-a Systematic Review. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] Yue Li. Management of patients with inflammatory bowel disease in pregnancy , 2019 .
[12] Nima Hamidi,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.
[13] S. Ng,et al. The Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21 st Century: A Systematic Review of Population-Based Studies , 2017 .
[14] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[15] С. Р. Абдулхаков. Четвертый конгресс европейской организации по изучению язвенного колита и болезни Крона (European croHN"s and Colitis oRGANizATioN, Ecco) , 2009 .